EnzymeBioSystems — key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2017)

-$95.8K

Total Assets (FY2017)

$44.2K

Total Equity (FY2017)

$40.1K

Cash Flows from Operating Activities (FY2017)

-$98.8K

Source: EnzymeBioSystems 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.